Page last updated: 2024-08-21

benzoxazoles and Acute Lymphoid Leukemia

benzoxazoles has been researched along with Acute Lymphoid Leukemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fruman, DA; Janes, MR; Jessen, KA; Li, LS; Lilly, MB; Limon, JJ; Liu, Y; Mallya, S; Martin, MB; Ren, P; Rommel, C; Sender, LS; Shieh, MP; Vu, C	1

Other Studies

1 other study(ies) available for benzoxazoles and Acute Lymphoid Leukemia

Article	Year
Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia, 2013, Volume: 27, Issue:3 Topics: Adult; Animals; Benzoxazoles; Bone Marrow; Cell Proliferation; Colony-Forming Units Assay; Disease Models, Animal; Female; Flow Cytometry; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; TOR Serine-Threonine Kinases; Treatment Outcome; Tumor Cells, Cultured	2013

Article

Year

Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia.

Leukemia, 2013, Volume: 27, Issue:3

Topics: Adult; Animals; Benzoxazoles; Bone Marrow; Cell Proliferation; Colony-Forming Units Assay; Disease Models, Animal; Female; Flow Cytometry; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred NOD; Mice, SCID; Philadelphia Chromosome; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Protein Kinase Inhibitors; Pyrimidines; TOR Serine-Threonine Kinases; Treatment Outcome; Tumor Cells, Cultured

2013